These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 12391846

  • 21. [Apoptotic cell death in rat embryo fibroblasts transformed by EiA + cHa-RAS oncogenes after gamma irradiation].
    Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV.
    Tsitologiia; 1998; 40(12):1017-24. PubMed ID: 10188216
    [Abstract] [Full Text] [Related]

  • 22. Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation.
    Smith ER, Smedberg JL, Rula ME, Hamilton TC, Xu XX.
    J Biol Chem; 2001 Aug 24; 276(34):32094-100. PubMed ID: 11402055
    [Abstract] [Full Text] [Related]

  • 23. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN, Jonasch E, Mosterman BC, Mier JW, Janssen RA.
    Cell Growth Differ; 2001 Nov 24; 12(11):543-50. PubMed ID: 11714635
    [Abstract] [Full Text] [Related]

  • 24. Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3',5'-monophosphate effects on prolactin promoter activity.
    Kievit P, Lauten JD, Maurer RA.
    Mol Endocrinol; 2001 Apr 24; 15(4):614-24. PubMed ID: 11266512
    [Abstract] [Full Text] [Related]

  • 25. Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast.
    Tresini M, Lorenzini A, Frisoni L, Allen RG, Cristofalo VJ.
    Exp Cell Res; 2001 Oct 01; 269(2):287-300. PubMed ID: 11570821
    [Abstract] [Full Text] [Related]

  • 26. The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation.
    Stewart S, Guan KL.
    J Biol Chem; 2000 Mar 24; 275(12):8854-62. PubMed ID: 10722731
    [Abstract] [Full Text] [Related]

  • 27. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T, Stewart S, Han M, Guan KL.
    EMBO J; 1998 Mar 16; 17(6):1717-27. PubMed ID: 9501093
    [Abstract] [Full Text] [Related]

  • 28. [Transcription factor NF-kappa B/RelA are constitutively activated and localized in the cell nuclei of E1A + cHa-Ras transformants].
    Darieva ZA, Pospelov VA, Pospelova TV.
    Tsitologiia; 1999 Mar 16; 41(7):622-7. PubMed ID: 10496024
    [Abstract] [Full Text] [Related]

  • 29. [The role of different kinase pathways of signal transduction in proliferation of E1A + Ras transformants].
    Abramova MV, Svetlikova SB, Grinkevich VV, Pospelov VA.
    Tsitologiia; 2005 Mar 16; 47(12):1071-81. PubMed ID: 16706195
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
    Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN.
    Oncogene; 2001 Mar 15; 20(11):1357-67. PubMed ID: 11313879
    [Abstract] [Full Text] [Related]

  • 32. [Anti-apoptotic and antiproliferative effect of bcl-2 gene transferred to E1A+cHa-ras-transformed cells].
    Tararova ND, Bulavin DV, Neliudova AM, Aksenov ND, Pospelov VA, Pospelova TV.
    Tsitologiia; 2002 Mar 15; 44(5):441-9. PubMed ID: 14696253
    [Abstract] [Full Text] [Related]

  • 33. PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.
    Su Z, Shi Y, Friedman R, Qiao L, McKinstry R, Hinman D, Dent P, Fisher PB.
    Nucleic Acids Res; 2001 Apr 15; 29(8):1661-71. PubMed ID: 11292838
    [Abstract] [Full Text] [Related]

  • 34. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells.
    Okajima E, Thorgeirsson UP.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):108-11. PubMed ID: 10733912
    [Abstract] [Full Text] [Related]

  • 35. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300.
    Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M.
    EMBO J; 2003 Jan 15; 22(2):281-91. PubMed ID: 12514134
    [Abstract] [Full Text] [Related]

  • 36. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
    Lo LW, Cheng JJ, Chiu JJ, Wung BS, Liu YC, Wang DL.
    J Cell Physiol; 2001 Sep 15; 188(3):304-12. PubMed ID: 11473356
    [Abstract] [Full Text] [Related]

  • 37. C/EBP beta and Elk-1 synergistically transactivate the c-fos serum response element.
    Hanlon M, Bundy LM, Sealy L.
    BMC Cell Biol; 2000 Sep 15; 1():2. PubMed ID: 11151091
    [Abstract] [Full Text] [Related]

  • 38. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1.
    Lim CP, Jain N, Cao X.
    Oncogene; 1998 Jun 04; 16(22):2915-26. PubMed ID: 9671412
    [Abstract] [Full Text] [Related]

  • 39. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A, Cuozzo C, Esposito I, Maggiolini M, Bonofiglio D, Vivacqua A, Garramone M, Weiss C, Bohmann D, Musti AM.
    Oncogene; 2002 Sep 19; 21(42):6434-45. PubMed ID: 12226747
    [Abstract] [Full Text] [Related]

  • 40. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit.
    Stevens JL, Cantin GT, Wang G, Shevchenko A, Shevchenko A, Berk AJ.
    Science; 2002 Apr 26; 296(5568):755-8. PubMed ID: 11934987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.